http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-2011026-I2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_baee372c55802742f9582e25c15ff11a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
filingDate 2011-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2012-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-2011026-I2
titleOfInvention Eribulin or a pharmaceutically acceptable salt thereof
priorityDate 1998-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134990500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419561839

Total number of triples: 16.